Answers are grounded in this paper and cite their sources.
These findings provide evidence for two major types of antiviral immune responses in long COVID. Seropositive patients showed coordinated cellular and humoral responses at least as high as those of recovered patients. In contrast, ELISA-seronegative long COVID patients showed overall low antiviral responses, with detectable specific CD4+ T cells and/or antibodies in close to half of patients (52.2%). These divergent findings in patients sharing a comparable spectrum of persistent symptoms raise the possibility of multiple etiologies in long COVID.
No takes yet. Share an insight, caveat, or question.
Kervevan et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: